Altimmune Statement on the Passing of Dr. Stephen Harrison
April 25 2024 - 5:24PM
The Altimmune team would like to express our sorrow and extend our
heartfelt condolences to Dr. Stephen Harrison’s family following
his tragic and unexpected passing.
Dr. Harrison’s countless contributions to advancing needed
treatments for metabolic liver disease will leave a profound and
lasting legacy throughout our field, with his patients and the
people engaged in understanding and treating liver disease. His
brilliance and vision were only rivaled by his eloquence, charisma
and steadfast commitment to improving the lives of people with
liver disease. He was a tireless advocate for patients and a deeply
respected advisor, investigator and friend to Altimmune.
We will miss him greatly as we adjust to this tremendous loss
for the community. We honor his memory and are grateful for having
known and worked with him.
Contact:Rich EisenstadtChief Financial
OfficerPhone: 240-654-1450reisenstadt@altimmune.com
Altimmune (NASDAQ:ALT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Altimmune (NASDAQ:ALT)
Historical Stock Chart
From Aug 2023 to Aug 2024